Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Yatharth Hospital & Trauma Care Services Ltd. Share Price
Day's Range
Day's Range
Low
₹918.00
High
₹972.00
Price Summary
| Previous Close | ₹965.30 |
|---|---|
| Day's Range | ₹918.00 - ₹972.00 |
| Open | ₹925.00 |
| 52 Week Range | ₹538.25 - ₹972.00 |
| Volume | 6,83,118 |
| Market Cap | ₹0.01 |
| Previous Close | ₹965.45 |
|---|---|
| Day's Range | ₹917.60 - ₹971.00 |
| Open | ₹923.05 |
| 52 Week Range | ₹538.15 - ₹971.00 |
| Volume | 26,528 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 6,474.66 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 51.35 |
| TTM EPS (₹) | 18.80 |
| P/E Ratio | 31.35 |
| Book Value(₹) | 5.09 |
| PAT Margin (%) | 14.83 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 14.35 |
| Trade Value ( ₹ in Lacs) | 250.72 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 51.35 |
| TTM EPS (₹) | 18.80 |
| P/E Ratio | 31.35 |
| Book Value(₹) | 5.09 |
| PAT Margin (%) | 14.83 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 14.35 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 2592.47 | 8856.21 |
| Expenses | N/A | N/A |
| PBT | 586.88 | 1717.39 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 420.4 | 1305.5 |
About Yatharth Hospital & Trauma Care Services Ltd.
| Founded | 2008 |
|---|---|
| Managing Director | Kapil Kumar |
| NSE Symbol | YATHARTH |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,56,113.58 | 1,901.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,39,321.25 | 9,015.05 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,923.81 | 4,888.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,26,386.71 | 8,790.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,14,508.45 | 1,147.95 | 835.50 - 835.50 |
| Cipla Ltd. | 1,13,778.04 | 1,408.40 | 1,165.70 - 1,165.70 |
| Lenskart Solutions Ltd. | 1,12,559.20 | 650.00 | 0.00 - 0.00 |
| Manipal Health Enterprises Ltd. | 1,04,736.91 | 796.25 | 625.45 - 625.45 |
| Laurus Labs Ltd. | 1,02,010.95 | 1,888.00 | 823.10 - 823.10 |
| Lupin Ltd. | 1,00,196.10 | 2,191.20 | 1,875.00 - 1,875.00 |
No Records Found
Latest News
Yatharth Hospital & Trauma Care Services informs about investors presentation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Yatharth Hospital & Trauma Care Services has informed that it enclosed the Investor’s Presentation on financial results of the Company for the Q1FY27. The above presentation will also be made available on website of the Company at https://www.yatharthhospitals.com/investors/corporate-announcements.
The above information is a part of company’s filings submitted to BSE.
Bal Pharma informs about AGM
Bal Pharma has informed that 39th AGM of Bal Pharma Limited Scheduled to be held on Thursday, September 24, 2026 at 11.00 AM through VC Mode.
The above information is a part of company’s filings submitted to BSE.
Gujarat Themis Biosyn informs about board meeting outcome
Gujarat Themis Biosyn has informed that pursuant to the approval of the board of directors of the company at its meeting held on August 25, 2026 and approval of the shareholders of the Company by way of a special resolution passed on August 22, 2026, the Board of Directors of the Company, in its meeting held on August 25, 2026, has inter alia considered and approved the following: (i) approval and adoption of the preliminary placement document dated August 25, 2026, and the draft of application form, in connection with the QIP; (ii) authorizing the opening of the proposed Issue of such number of Equity Shares to eligible QIBs through a qualified institutions placement under Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”) and Section 42 and 62 (1) (c) of the Companies Act, 2013, read with Rule 14 of the Companies (Prospectus and Allotment of Securities) Rules, 2014, each as amended on August 25, 2026; and (iii) approved the floor price for the QIP, as prescribed under SEBI ICDR Regulations.
The above information is a part of company’s filings submitted to BSE.
Broach Lifecare Hospital informs about resignation of CFO
Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Broach Lifecare Hospital has informed that Company has received resignation letter dated 24th August, 2026, from URVI MRUNAL HINDIA from the position of Chief Financial Officer (CFO) with effect from closure of business hours 31st August, 2026 and the same is acknowledged by the Company today, on 25th August, 2026. Further, the disclosure of information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular- SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30 January 2026 are attached as Annexure-I.
The above information is a part of company’s filings submitted to BSE.
Shanmuga Hospital submits annual report
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Yatharth Hospital & Trauma Care Services Ltd. is ₹965.30 as of 2026-08-26.
The market capitalisation of Yatharth Hospital & Trauma Care Services Ltd. is ₹9,302.53 as of 2026-08-26.
The 1-year return of Yatharth Hospital & Trauma Care Services Ltd. is 258.20% as of 2026-08-26.
The P/E ratio of Yatharth Hospital & Trauma Care Services Ltd. is 31.35 as of 2026-08-27.
The 52-week high and low of Yatharth Hospital & Trauma Care Services Ltd. are ₹972.00 and ₹538.25, respectively, as of 2026-08-26.
People Also Ask
Yatharth Hospital & Trauma Care Services Ltd. collaborates with pharmaceutical companies and other healthcare entities through clinical practices, procurement of medical equipment, and integration of healthcare technologies. Its hospitals may also serve as clinical settings for treatment protocols and the use of advanced medical devices, while partnering with suppliers to maintain modern healthcare infrastructure.
Yatharth Hospital & Trauma Care Services Ltd. operates multi-specialty hospitals, primarily located in the National Capital Region (NCR). Its facilities provide a range of healthcare services, including trauma care, cardiology, orthopedics, and critical care, supported by intensive care units and related medical infrastructure.
Explore More Articles About Indices
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
